Matthias Kopp

7.0k total citations · 1 hit paper
136 papers, 3.5k citations indexed

About

Matthias Kopp is a scholar working on Physiology, Immunology and Allergy and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Matthias Kopp has authored 136 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Physiology, 51 papers in Immunology and Allergy and 49 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Matthias Kopp's work include Asthma and respiratory diseases (69 papers), Allergic Rhinitis and Sensitization (46 papers) and Neonatal Respiratory Health Research (22 papers). Matthias Kopp is often cited by papers focused on Asthma and respiratory diseases (69 papers), Allergic Rhinitis and Sensitization (46 papers) and Neonatal Respiratory Health Research (22 papers). Matthias Kopp collaborates with scholars based in Germany, Switzerland and United States. Matthias Kopp's co-authors include Gesine Hansen, Andrea Heinzmann, Erika von Mutius, R. Urbanek, Inke R. König, Oliver Fuchs, Ulrich Wahn, María Rescigno, Todd R. Klaenhammer and Michiel Kleerebezem and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and Nature reviews. Immunology.

In The Last Decade

Matthias Kopp

124 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

What is precision medicine?

2017 356 citations Inke R. König, Oliver Fuchs et al. European Respiratory Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthias Kopp Germany	32	1.4k	1.1k	850	644	460	136	3.5k
Supinda Bunyavanich United States	28	1.2k 0.9×	1.2k 1.1×	355 0.4×	858 1.3×	409 0.9×	76	3.5k
Markus Ege Germany	33	3.1k 2.3×	1.2k 1.1×	1.2k 1.5×	1.3k 2.1×	521 1.1×	75	6.2k
Bianca Schaub Germany	29	1.8k 1.3×	688 0.7×	790 0.9×	464 0.7×	347 0.8×	110	3.4k
Waltraud Eder Austria	19	3.3k 2.4×	1.3k 1.2×	1.1k 1.3×	738 1.1×	449 1.0×	30	5.2k
Udo Herz Germany	38	2.8k 2.1×	1.7k 1.6×	813 1.0×	941 1.5×	753 1.6×	80	6.1k
Leonard Bielory United States	44	1.6k 1.2×	3.1k 3.0×	592 0.7×	475 0.7×	1.3k 2.9×	269	6.9k
David Carr United States	33	2.6k 1.9×	1.2k 1.1×	917 1.1×	560 0.9×	604 1.3×	106	5.9k
Albrecht Bufe Germany	37	2.9k 2.1×	2.3k 2.2×	863 1.0×	618 1.0×	1.0k 2.2×	102	5.2k
Susanne Krauss‐Etschmann Germany	36	1.1k 0.8×	400 0.4×	934 1.1×	975 1.5×	176 0.4×	95	4.1k
Stefan Zielen Germany	41	2.1k 1.5×	1.5k 1.4×	1.7k 2.0×	1.1k 1.7×	592 1.3×	243	5.5k

Countries citing papers authored by Matthias Kopp

Since Specialization

Citations

This map shows the geographic impact of Matthias Kopp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Kopp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Kopp more than expected).

Fields of papers citing papers by Matthias Kopp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Kopp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Kopp. The network helps show where Matthias Kopp may publish in the future.

Co-authorship network of co-authors of Matthias Kopp

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Kopp. A scholar is included among the top collaborators of Matthias Kopp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Kopp. Matthias Kopp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stichtenoth, Guido, Michael Zemlin, Isabell Ricklefs, et al.. (2025). Influenza Immunization in Very-Low-Birth-Weight Infants: Epidemiology and Long-Term Outcomes. Vaccines. 13(1). 42–42. 1 indexed citations

Riedel, Thomas, et al.. (2025). Clinical outcomes and risk factors associated with neonatal transports in Switzerland: a retrospective single-centre cohort study. Swiss Medical Weekly. 155(10). 4307–4307.

Omony, Jimmy, Clemens Thölken, Azam Salimi, et al.. (2024). Urinary eosinophil‐derived neurotoxin is associated with reduced lung function in pediatric asthma. Pediatric Allergy and Immunology. 35(6). e14172–e14172. 2 indexed citations

Ankermann, Tobias, Carl‐Peter Bauer, Peter Fischer, et al.. (2024). Position paper dupilumab and vaccination. Allergo Journal International. 34(1). 1–9.

Duppenthaler, Andrea, Carmen Casaulta, Thomas Riedel, et al.. (2024). Postpandemic fluctuations of regional respiratory syncytial virus hospitalization epidemiology: potential impact on an immunization program in Switzerland. European Journal of Pediatrics. 183(12). 5149–5161. 2 indexed citations

Stahl, Mirjam, Jobst Roehmel, Monika Eichinger, et al.. (2024). Long-Term Impact of Lumacaftor/Ivacaftor Treatment on Cystic Fibrosis Disease Progression in Children 2–5 Years of Age Homozygous for F508del-CFTR : A Phase 2, Open-Label Clinical Trial. Annals of the American Thoracic Society. 21(11). 1550–1559. 5 indexed citations

Conti, Diego M., Vibeke Backer, Leif Bjermer, et al.. (2024). EUFOREUM Berlin 2023: Optimizing care for type 2 inflammatory diseases from clinic to AI: A pediatric focus. Pediatric Allergy and Immunology. 35(7).

Maison, Nicole, Lennart Riemann, David S. DeLuca, et al.. (2023). Increased breath naphthalene in children with asthma and wheeze of the All Age Asthma Cohort (ALLIANCE). Journal of Breath Research. 18(1). 16003–16003. 1 indexed citations

Stahl, Mirjam, Jobst Roehmel, Monika Eichinger, et al.. (2023). Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for F508del-CFTR : A Phase 2 Placebo-controlled Clinical Trial. Annals of the American Thoracic Society. 20(8). 1144–1155. 13 indexed citations

10.

Abdo, Mustafa, Anne‐Marie Kirsten, Erika von Mutius, et al.. (2023). Minimal clinically important difference for impulse oscillometry in adults with asthma. European Respiratory Journal. 61(5). 2201793–2201793. 20 indexed citations

11.

Fortmann, Mats Ingmar, Alexander Humberg, Kirstin Faust, et al.. (2023). Respiratory Syncytial Virus Prophylaxis With Palivizumab Is Not Associated With Improved Lung Function in Infants of Very Low Birth Weight at Early School Age. 2(1). 100026–100026. 1 indexed citations

12.

Klimek, Ludger, Randolf Brehler, Ralph Mösges, et al.. (2022). Update about Oralair® as a treatment for grass pollen allergic rhinitis. Human Vaccines & Immunotherapeutics. 18(5). 2066424–2066424. 2 indexed citations

13.

Abdo, Mustafa, Frederik Trinkmann, Anne‐Marie Kirsten, et al.. (2021). The Relevance of Small Airway Dysfunction in Asthma with Nocturnal Symptoms. Journal of Asthma and Allergy. Volume 14. 897–905. 16 indexed citations

14.

Skevaki, Chrysanthi, Nina Timmesfeld, Markus Weckmann, et al.. (2021). Allergen extract‐ and component‐based diagnostics in children of the ALLIANCE asthma cohort. Clinical & Experimental Allergy. 51(10). 1331–1345. 7 indexed citations

15.

Vermeulen, Cornelis J., Alen Faiz, Brian G. Oliver, et al.. (2021). COL4A3expression in asthmatic epithelium depends on intronic methylation and ZNF263 binding. ERJ Open Research. 7(2). 802–2020. 6 indexed citations

16.

Weckmann, Markus, Inke R. König, André Franke, et al.. (2018). Rhinovirus infections change DNA methylation and mRNA expression in children with asthma. PLoS ONE. 13(11). e0205275–e0205275. 41 indexed citations

17.

Grecian, W. James, Matthew J. Witt, Martin J. Attrill, et al.. (2016). Seabird diversity hotspot linked to ocean productivity in the Canary Current Large Marine Ecosystem. Biology Letters. 12(8). 54 indexed citations

18.

Weckmann, Markus, Matthias Kopp, Andrea Heinzmann, & Joërg Mattes. (2010). Haplotypes covering the TNFSF10 gene are associated with bronchial asthma. Pediatric Allergy and Immunology. 22(1-Part-I). 25–30. 6 indexed citations

19.

Kopp, Matthias, et al.. (2008). Randomized, Double-Blind, Placebo-Controlled Trial of Probiotics for Primary Prevention: No Clinical Effects of Lactobacillus GG Supplementation. PEDIATRICS. 121(4). e850–e856. 282 indexed citations

20.

Kopp, Matthias, et al.. (1999). Making a difference: immunizing infants and children.. PubMed. 31(1). A2–6; quiz A7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact